This webinar by Evana Lopez, Sweden and Matthias Liechti, Switzerland, was recorded on 7 February 2025 as part of the ‘A European perspective on psychedelics research, from pharmacology to clinical effects’ webinar series, organised by the ECNP Psychedelic Research Network.
This talk introduce the field of psychedelics research and give you a basic understanding of what psychedelics are from a pharmacological point of view. From there, a closer look is taken at the limited use program in Switzerland.
About the ‘A European perspective on psychedelics research, from pharmacology to clinical effects’ webinar series
In this webinar series, the wide scope of psychedelics research conducted at various centers in Europe is explored. Throughout three sessions, a wide range of topics is covered: from pharmacology and preclinical investigations to the clinical trials conducted in psychiatry. The sessions in this series build upon each other but can also be viewed in isolation. In each session, cutting-edge research is presented by esteemed researchers from different universities in Europe.
This is the first session in the series.
Second session: Preclinical and clinical evidence on mechanisms of action, translational research from Sweden and Denmark
Third session: Clinical applications in psychedelics; current evidence from meta-analysis and experiences from Sweden
Views and opinions expressed in these videos are those of the presenters and do not necessarily reflect the official position of ECNP. The content of these videos should not be used in any way as the basis for treatment decisions.
